APRIL based therapeutic strategies to target BCMA and TACI in multiple myeloma
Myeloma remains largely incurable and there is an unmet need for new therapies. B-cell maturation antigen (BCMA) is an attractive therapeutic target due to its restricted expression on normal and malignant plasma cells(PC). A natural ligand for BCMA is a proliferating ligand (APRIL) which also natur...
| Main Author: | |
|---|---|
| Published: |
University College London (University of London)
2017
|
| Subjects: | |
| Online Access: | https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.724624 |